GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Cloughesy, T., Alexander, B., Berry, D. A., Colman, H., De Groot, J., Ellingson, B. M., Gordon, G. B., Khasraw, M., Lassman, A. B., Lee, E., Lim, M., Mellinghoff, I. K., Nelli, A., Perry, J. R., Sulman, E. P., Tanner, K., Weller, M., Wen, P. Y., Yung, W., Gbm Agile Investigators LIPPINCOTT WILLIAMS & WILKINS. 2022

View details for Web of Science ID 000863680304830